Giulidori P, Galli-Kienle M, Catto E, Stramentinoli G
J Biol Chem. 1984 Apr 10;259(7):4205-11.
S-Adenosylmethionine (AdoMet) is metabolized through three main pathways, i.e. (a) transfer of its methyl group to a variety of methyl acceptors, (b) decarboxylation followed by aminopropylation leading to polyamine synthesis, and (c) cleavage of the bond between the sulfur atom and carbon 4 of the amino acid chain, resulting in formation of methylthioadenosine and homoserine thiolactone. In this study the metabolism of AdoMet through these pathways was studied after intravenous administration to rats of [1-14C]-, [3,4-14C]-, [methyl-14C]-, and [35S]AdoMet at various doses. The relative utilization of AdoMet and methionine was also investigated. The results show that intravenously administered AdoMet is efficiently metabolized in vivo up to the highest tested dose (250 mumol X kg-1 body weight), about two-thirds of the metabolized compound being utilized via transmethylation and cleavage to methylthioadenosine and one-third via decarboxylation. The efficient incorporation of the methyl group of AdoMet into muscle creatine indicates unambiguously that the compound is taken up and metabolized by the liver. Moreover, intravenously administered AdoMet is shown to be a better precursor than methionine both in creatine formation and in the utilization of the sulfur atom in transsulfuration reactions.
S-腺苷甲硫氨酸(AdoMet)通过三条主要途径进行代谢,即:(a)将其甲基转移至多种甲基受体;(b)脱羧后进行氨丙基化反应,从而合成多胺;(c)切断硫原子与氨基酸链中碳4之间的键,生成甲硫基腺苷和高丝氨酸硫内酯。在本研究中,给大鼠静脉注射不同剂量的[1-14C]-、[3,4-14C]-、[甲基-14C]-和[35S]AdoMet后,对AdoMet通过这些途径的代谢情况进行了研究。同时还研究了AdoMet和甲硫氨酸的相对利用率。结果表明,静脉注射的AdoMet在体内可高效代谢至最高测试剂量(250 μmol·kg-1体重),约三分之二的代谢产物通过转甲基作用以及裂解生成甲硫基腺苷进行利用,三分之一通过脱羧作用进行利用。AdoMet的甲基有效掺入肌肉肌酸中,明确表明该化合物被肝脏摄取并代谢。此外,静脉注射的AdoMet在肌酸形成以及转硫反应中硫原子的利用方面均显示出比甲硫氨酸更好的前体作用。